7.94 (dd, J ¼ 8.2, 1.8 Hz, 1H, Ar-H), 7.71 (td, J ¼ 7.8, 1.4 Hz, 2H,
Ar-H), 7.52 (d, J ¼ 8.2 Hz, 1H, Ar-H), 7.43 (qd, J ¼ 8.2, 1.6 Hz,
2H, Ar-H), 7.01–6.91 (m, 4H, Ar-H) ppm. IR (KBr): n ¼ 3435,
2959, 2857, 1683, 1615, 1592, 1559, 1453, 1432, 1361, 1278, 1193,
761, 679 cmꢁ1. HRMS (MALDI-TOF, positive mode, CH2Cl2):
m/z ¼ 361.1176 [M]+ (C21H16N2O4: calcd 361.1183, Dm ¼ ꢁ1.94
ppm).
cyclohexane-H), 1.92–1.94 (m, 2H, cyclohexane-H), 1.52–1.53
(m, 20H, cyclohexane-H and tert-butyl), 1.40–1.41 (m, 2H,
cyclohexane-H), 1.29 (s, 18H, tert-butyl) ppm. IR (KBr): n ¼
3435, 2952, 2866, 1610, 1528, 1433, 1319, 1254, 1168, 781 and 545
cmꢁ1. HRMS (MALDI-TOF, positive mode, CH2Cl2): m/z ¼
739.3687 [M]+ (C36H52N2O2Pt: calcd 739.3674, Dm ¼ ꢁ1.76
ppm). UV-Vis (CH2Cl2, 20 ꢀC): lmax [log(3 dmꢁ3 molꢁ1 cmꢁ1)] ¼
253 (4.59), 316 (4.09), 353 (4.15), 437 (3.74) nm.
C36H52N2O2Pt$0.5H2O (748.9): calcd C 57.74, H 7.13, N 3.74;
found: C 57.44, H 7.08, N 3.79%.
1e:
0.97 mmol) and 3,5-di-tert-butyl-2-hydroxybenzaldehyde
4,5-bis(dodecyloxy)benzene-1,2-diamine
(463
mg,
1
(500 mg, 2.14 mmol) were used. Yield: 547 mg (62%). H NMR
(400 MHz, CDCl3): d ¼ 13.66 (s, 2H, OH), 8.63 (s, 2H, C]NH),
7.41 (d, 2H, J ¼ 2.4 Hz, Ar-H), 7.20 (d, 2H, J ¼ 2.4 Hz, Ar-H),
6.81 (s, 2H, Ar-H), 4.07 (m, 4H, -OCH2-), 1.84–1.88 (m, 4H,
-OCH2CH2-), 1.49–1.56 (m, 6H), 1.43 (s, 18H, tert-butyl), 1.35
(m, 4H), 1.32 (s, 18H, tert-butyl), 1.27 (m, 26H), 0.88 (s, 6H,
-CH3) ppm. IR (KBr): n ¼ 3435, 2955, 2924, 1615, 1579, 1513,
1472, 1439, 1361, 1263, 1173, 773, 686 cmꢁ1. HRMS (MALDI-
TOF, positive mode, CH2Cl2): m/z ¼ 909.7403 [M + H]+
(C21H16N2O4: calcd 361.1183, Dm ¼ ꢁ4.51 ppm).
2b: Schiff base ligand 1b (100 mg, 0.17 mmol), KOH (19 mg,
0.34 mmol) and K2PtCl4 (84 mg, 0.20 mmol) were used. Yield: 34
1
mg (26%). H NMR (400 MHz, CDCl3): d ¼ 7.96 (s, 2H, C]
NH), 7.50 (d, 2H, J ¼ 2.8 Hz, Ar-H), 7.28 (d, 2H, J ¼ 2.6 Hz, Ar-
H), 3.50–3.53 (m, 2H, cyclohexane-H), 2.59–2.62 (m, 2H,
cyclohexane-H), 1.88–1.91 (m, 2H, cyclohexane-H), 1.51–1.52
(m, 2H, cyclohexane-H), 1.48 (m, 18H, tert-butyl), 1.30–1.36 (m,
2H, cyclohexane-H) ppm. IR (KBr): n ¼ 3436, 2944, 2867, 1623,
1526, 1429, 1313, 1257, 1164, 778 and 582 cmꢁ1. HRMS
(MALDI-TOF, positive mode, CH2Cl2): m/z ¼ 786.0629 [M]+
(C28H34Br2N2O2Pt: calcd 786.0609, Dm ¼ 2.54 ppm). UV-Vis
(CH2Cl2, 20 ꢀC): lmax [log(3 dmꢁ3 molꢁ1 cmꢁ1)] ¼ 261 (4.62), 322
(4.08), 351 (4.10), 441 (3.74) nm. C28H34Br2N2O2Pt (785.47):
calcd C 42.82, H 4.36, N 3.57; found: C 42.69, H 4.55, N 3.52%.
2c: Schiff base ligand 1c (100 mg, 0.18 mmol), KOH (21 mg,
0.37 mmol) and K2PtCl4 (92 mg, 0.22 mmol) were used. Yield: 96
Preparation of asymmetric Schiff base ligand 1f
A solution of 3,5-di-tert-butyl-2-hydroxybenzaldehyde (1000 mg,
4.27 mmol), trans-diaminocyclohexane mono(hydrogen chlo-
ꢀ
ride) (645 mg, 4.27 mmol) and 4 A molecular sieves (500 mg) in
anhydrous methanol (15 mL) were stirred overnight at room
temperature under nitrogen. Then, 5-bromo-3-tert-butyl-2-
hydroxybenzaldehyde (1098 mg, 4.27 mmol) in anhydrous
CH2Cl2 (20 mL) and anhydrous NEt3 (863 mg, 8.54 mmol) were
added. The mixture was stirred at room temperature for an
additional 10 h. The residue after solvent evaporation was
purified by silica-gel column chromatography using a solvent
mixture of hexane and CH2Cl2 as the eluent to give a yellow solid
1
mg (71%). H NMR (400 MHz, CDCl3): d ¼ 9.64 (s, 1H, C]
NH), 8.87 (s, 1H, C]NH), 8.37 (dd, 1H, J ¼ 4.4, 0.8 Hz, Ar-H),
8.29 (dd, 1H, J ¼ 8.8, 0.8 Hz, Ar-H), 7.70 (td, 2H, J ¼ 1.6, 0.8 Hz,
Ar-H), 7.47 (d, 1H, J ¼ 2.0 Hz, Ar-H), 7.31 (d, 1H, J ¼ 2.0 Hz,
Ar-H), 7.17 (dd, 1H, J ¼ 8.0, 4.8 Hz, Ar-H), 1.59 (s, 18H, tert-
butyl), 1.35 (s, 18H, tert-butyl) ppm. IR (KBr): n ¼ 3435, 2953,
2867, 1598, 1519, 1441, 1360, 1268, 1170, 782 and 542 cmꢁ1
.
1
of 1f. Yield: 1632 mg (67%). H NMR (400 MHz, CDCl3): d ¼
HRMS (MALDI-TOF, positive mode, CH2Cl2): m/z ¼ 735.3263
[M + H]+ (C35H45N3O2Pt: calcd 735.3235, Dm ¼ 3.81 ppm). UV-
Vis (CH2Cl2, 20 ꢀC): lmax [log(3 dmꢁ3 molꢁ1 cmꢁ1)] ¼ 258 (4.47),
373 (4.37), 389 (4.47), 486 (3.78), 561 (3.78) nm.
C35H45N3O2Pt$1/3CH2Cl2 (763.14): calcd C 55.61, H 6.03, N
5.51; found: C 55.44, H 5.89, N 5.57%.
13.95 (s, 1H, OH), 13.59 (s, 1H, OH), 8.26 (s, 1H, C]NH), 8.18
(s, 1H, C]NH), 7.31 (s, 1H, Ar-H), 7.28 (s, 1H, Ar-H), 7.08 (s,
1H, Ar-H), 6.94 (s, 1H, Ar-H), 3.30 (m, 2H, cyclohexane-H),
1.73–1.95 (m, 8H, cyclohexane-H), 1.42 (s, 9H, tert-butyl), 1.37
(s, 9H, tert-butyl), 1.23 (s, 9H, tert-butyl) ppm. IR (KBr): n ¼
3429, 2956, 2862, 1629, 1469, 1439, 1361, 1272, 1174, 772,
644 cmꢁ1. FAB MS (positive mode): m/z ¼ 570 [M]+.
2d: Schiff base ligand 1d (100 mg, 0.28 mmol), KOH (31 mg,
0.55 mmol) and K2PtCl4 (138 mg, 0.33 mmol) were used. Yield:
112 mg (68%). 1H NMR (400 MHz, [D6]DMSO): d ¼ 9.60 (s, 1H,
C]NH), 9.57 (s, 1H, C]NH), 8.40 (s, 1H, Ar-H), 8.37 (d, 1H,
J ¼ 8.8 Hz, Ar-H), 8.10 (dd, 1H, J ¼ 8.4, 0.8 Hz, Ar-H), 7.94 (td,
2H, J ¼ 7.8, 2.0 Hz, Ar-H), 7.58–7.64 (m, 2H, Ar-H), 7.16 (d, 2H,
J ¼ 4.0 Hz, Ar-H), 6.83 (qd, 2H, J ¼ 8.0, 0.6 Hz, Ar-H) ppm. IR
(KBr): n ¼ 3429, 2953, 1612, 1524, 1385, 1366, 1253, 1183, 779
and 545 cmꢁ1. HRMS (MALDI-TOF, positive mode, CH2Cl2):
General procedure for the preparation of platinum(II) Schiff base
complexes 2a–2f
A solution of one equivalent of the Schiff base ligand 1 and two
equivalents of ꢀKOH was stirred about 0.5 h in DMF under
nitrogen at 70 C. Then, excess K2PtCl4 in DMSO (5 mL) was
added and continuously stirred for 24 h under nitrogen at 70 ꢀC.
The reaction mixture was extracted with CH2Cl2 and washed
with water several times. The residue after solvent evaporation
was purified by silica-gel column chromatography using a
solvent mixture of hexane and CH2Cl2 as eluent to give an orange
solid.
m/z ¼ 591.9498 [M]+ (C21H13KN2O4Pt: calcd 591.5152, Dm
¼
7.34 ppm). UV-Vis (DMSO, 20 ꢀC): lmax [log(3 dmꢁ3 molꢁ1
cmꢁ1)] ¼ 255 (4.33), 311 (3.90), 321 (3.94), 359 (4.18), 379 (4.22),
454 (3.14), 526 (3.30) nm. C21H13KN2O4Pt (591.52): calcd C
42.64, H 2.22, N 4.74; found: C 42.53, H 2.32, N 4.89%.
2e: Schiff base ligand 1e (200 mg, 0.22 mmol), KOH (25 mg,
0.44 mmol) and K2PtCl4 (110 mg, 0.26 mmol) were used. Yield:
75 mg (31%). 1H NMR (400 MHz, CDCl3): d ¼ 8.61 (s, 2H, C]
NH), 7.63 (s, 2H, Ar-H), 7.36 (s, 2H, Ar-H), 7.31 (s, 2H, Ar-H),
4.14 (m, 4H, -OCH2-), 1.91 (m, 4H, -OCH2CH2-), 1.57 (s, 18H,
tert-butyl), 1.27–1.41 (m, 54H), 0.88 (s, 6H, -CH3) ppm. IR
2a: Schiff base ligand 1a (100 mg, 0.18 mmol), KOH (21 mg,
0.37 mmol) and K2PtCl4 (91 mg, 0.22 mmol) were used. Yield:
51 mg (38%). 1H NMR (400 MHz, CDCl3): d ¼ 8.07 (s, 2H, C]
NH), 7.56 (d, 2H, J ¼ 2.4 Hz, Ar-H), 7.08 (d, 2H, J ¼ 2.4 Hz, Ar-
H), 3.43–3.45 (m, 2H, cyclohexane-H), 2.65–2.68 (m, 2H,
This journal is ª The Royal Society of Chemistry 2012
J. Mater. Chem., 2012, 22, 16448–16457 | 16455